Most 510(k) quotes look calm until the scope starts sprouting little horns. A founder asks for “FDA help,” a boutique hears “predicate strategy, testing plan, eSTAR assembly, labeling, responses, and a small mountain goat of documentation,” and suddenly the budget feels foggy. Today, in about 15 minutes, this guide will help you understand how US FDA regulatory affairs boutiques price 510(k) support, what is usually included, what is not, and where expensive surprises hide. The goal is not to make you a regulatory attorney over breakfast. It is to help you buy support with clear eyes, steady hands, and fewer invoice-shaped thunderclouds.
Why 510(k) Pricing Feels Confusing
A 510(k) project is not one task. It is a bundle of judgment calls, document work, evidence mapping, testing coordination, reviewer psychology, and deadline management. That is why two boutiques can look at the same device and quote very different fees without either being dishonest.
One boutique may assume you already have a clean design history file, usable bench testing, polished labeling, and a strong predicate. Another may assume those items need repair. The first quote looks cheaper. The second quote may be more realistic. The difference is not always price. Sometimes it is x-ray vision.
I once saw a startup request a “simple 510(k) submission” for a device with Bluetooth, a reusable patient-contact accessory, and a software app that made clinical recommendations. The founder meant simple compared with a PMA. The consultant heard software documentation, cybersecurity, biocompatibility, electrical safety, usability, labeling, and a predicate comparison that needed careful stitching. Same sentence. Two universes.
510(k) work is priced around uncertainty
Regulatory boutiques are not just charging for hours. They are pricing the risk that the project will expand after the first document review. A missing test report, unclear intended use, weak predicate, or messy labeling claim can add weeks of work. The quote must absorb some of that unknown.
The FDA fee is not the consultant fee
The FDA charges a separate medical device user fee for most 510(k) submissions. For FY 2026, the FDA listed the standard 510(k) user fee at $26,067 and the small business fee at $6,517. Those amounts are paid to FDA, not to your consultant. A boutique’s professional fee sits on top of that, rather like paying both the toll booth and the driver who knows the mountain road.
- The FDA user fee is separate from consultant fees.
- Device complexity can matter more than company size.
- A cheap quote with vague scope can become expensive later.
Apply in 60 seconds: Ask whether the quoted fee includes FDA response support after submission.
What Regulatory Affairs Boutiques Actually Sell
A good regulatory affairs boutique sells more than document formatting. The real value is structured judgment: what belongs in the submission, what can be left out, what claim might trigger extra evidence, and how to avoid inviting a reviewer into a swamp.
The FDA defines a 510(k) as a premarket submission showing that a device is substantially equivalent to a legally marketed predicate device. That sounds tidy. In practice, substantial equivalence requires careful comparison of intended use, technological characteristics, performance data, labeling, and risk controls.
Strategy before paperwork
The first layer is regulatory strategy. This may include classification checks, product code review, predicate search, submission type selection, and early gap assessment. For founders, this is where a boutique can save money by saying, gently but firmly, “Do not build the castle on this predicate.”
A regulatory strategy memo may feel less satisfying than a finished eSTAR package, but it can prevent the expensive theater of submitting the wrong story. In medical devices, a bad predicate is not a speed bump. It is a trapdoor with office lighting.
Submission preparation
The second layer is preparation. This may include writing or editing the device description, substantial equivalence discussion, indications for use, software documentation summaries, sterilization details, biocompatibility rationale, electrical safety summary, risk management overview, labeling review, and administrative materials.
Since FDA requires most 510(k)s to be submitted using eSTAR unless exempted, boutiques also price the practical work of building the package inside FDA’s structured template. eSTAR helps organize the submission, but it does not magically create sound evidence. A template is a bowl. You still need soup.
Project management and reviewer response
The third layer is coordination. Boutique teams often chase test labs, align engineering inputs, edit labeling, track open questions, and manage FDA interactions. When FDA asks for additional information, the consultant’s job shifts from author to translator, negotiator, and document surgeon.
That is why response support can be priced separately. It is unpredictable. Some FDA questions are simple. Others arrive wearing steel-toed boots.
Common 510(k) Pricing Models
Most US FDA regulatory affairs boutiques use one of four pricing models: hourly, fixed fee, phased fixed fee, or monthly retainer. Each can be fair. Each can also become a tiny accounting raccoon if scope is unclear.
Hourly pricing
Hourly pricing is common when the work is uncertain. A boutique may charge hourly for early strategy, document review, FDA Q-sub preparation, gap assessment, or response support. Senior regulatory consultants often command higher rates because they can spot the one sentence that would otherwise cost three months.
| Model | Best For | Watch-Out |
|---|---|---|
| Hourly | Unclear scope, early strategy, FDA responses | Budget can drift without weekly caps |
| Fixed fee | Defined submission package with stable inputs | Exclusions may hide major work |
| Phased fixed fee | Startups that need decision gates | Later phases may be repriced after gaps appear |
| Monthly retainer | Ongoing regulatory department support | Unused hours or unclear deliverables |
Fixed-fee pricing
Fixed-fee pricing is attractive because it gives the buyer a number. It works best when the boutique has reviewed enough materials to know what it is buying into. If the consultant has not seen your test reports, labeling, risk file, and predicate logic, a fixed fee may be more of a weather forecast than a quote.
A boutique may quote a fixed fee for a Traditional 510(k) package, then exclude new test protocols, lab remediation, clinical evaluation, software documentation creation, cybersecurity plan drafting, translations, and FDA additional information responses. That is not automatically unfair. It must be visible.
Phased pricing
Phased pricing is often the cleanest model for early teams. A project may be split into regulatory assessment, gap analysis, testing plan, submission drafting, final eSTAR assembly, submission support, and FDA response support. Each gate gives the team a chance to stop, budget, or redirect.
I like phased pricing for founders because it turns a fog bank into stepping stones. Nobody has to pretend the whole path is known on day one. The boutique can say, “Here is phase one. After we inspect the engine, we will price the road trip.”
Retainers
Retainers work when the company needs regular regulatory help beyond one submission. This may include product changes, complaint handling, labeling review, quality system support, advertising claim review, and supplier questions. A retainer is less ideal when the buyer only needs one well-defined deliverable.
For teams building regulated operational systems, it may help to read related material on US HIPAA compliance consulting pricing and scope, because many of the same scope-control habits apply: define the deliverable, define the evidence, define the owner, then define the fee.
Typical Cost Ranges and Fee Drivers
Public prices vary, and many boutiques do not publish rate cards. Still, buyers commonly see professional fees for 510(k) support range from low five figures for narrow advisory help to six figures for complex, full-service submissions. The budget depends less on the word “510(k)” and more on the device, claims, testing burden, and state of your documents.
For a simple device with a clear predicate, complete testing, and mature labeling, a boutique may provide targeted support at a relatively contained fee. For a software-heavy, connected, reusable, sterile, patient-contact, diagnostic, or home-use device, the quote climbs because the submission has more rooms, more wires, and more places for gremlins to hide.
Cost table: realistic budget buckets
| Support Level | Possible Professional Fee Range | What It May Include |
|---|---|---|
| Strategy only | $3,000 to $15,000+ | Classification check, predicate review, gap memo, submission path advice |
| Targeted review | $8,000 to $30,000+ | Review of draft 510(k), RTA check, labeling comments, risk review |
| Standard full support | $35,000 to $90,000+ | Submission writing, eSTAR assembly, project management, final QC |
| Complex full support | $90,000 to $200,000+ | Software, cybersecurity, usability, biocompatibility, sterilization, lab coordination, response planning |
These are market-style planning ranges, not promises. The FDA fee, test lab fees, quality system work, legal review, clinical work, translations, and manufacturing readiness are separate unless the proposal says otherwise.
Major fee drivers
The biggest fee drivers usually include intended use complexity, predicate strength, technological differences, software level of concern, cybersecurity expectations, electrical safety standards, biocompatibility, sterilization, shelf life, usability, clinical data needs, and whether the company already has a quality system that can produce credible records.
One operations leader told me, “We have all the data.” Then the folder arrived. It had lab screenshots, draft emails, and a spreadsheet named final-final-really-final.xlsx. The science was promising. The evidence package was wearing slippers to a board meeting.
Do not forget testing costs
Consultant fees are often not the largest cost. Bench testing, electrical safety, EMC, software validation, usability studies, biocompatibility, sterilization validation, packaging validation, and shelf-life work can outgrow the consultant budget. Device firms with physical goods may also benefit from thinking about regulated production inputs early, much like the quality and material choices discussed in US specialty packaging engineering.
- FDA user fees are paid separately.
- Testing can exceed consulting fees.
- Weak documentation turns cheap quotes into change orders.
Apply in 60 seconds: Build a budget line for testing, FDA fees, and consultant fees before comparing proposals.
Scope Items That Change the Quote
The most important pricing question is not “How much is a 510(k)?” It is “What work are we buying?” Scope is the quiet machinery inside the price. When scope is vague, the project begins to rattle.
Predicate strategy
A strong predicate can simplify the story. A weak predicate can force additional justification, testing, or even a different regulatory path. Boutiques may charge separately for predicate research because it requires both database search and regulatory judgment.
Testing plan and lab coordination
Some boutiques write test plans, review protocols, coordinate with labs, and review reports. Others only incorporate final reports into the submission. If lab coordination is excluded, someone on your team must drive that bus without clipping a mailbox.
Software and cybersecurity
Software documentation can expand scope quickly. Connected devices, mobile apps, cloud features, AI-adjacent claims, data transfer, user authentication, and update mechanisms all require care. NIST is often relevant for cybersecurity thinking, while FDA guidance sets device-specific expectations.
Teams building software-driven operational tools may recognize similar scoping issues from AI-driven consent orchestration and digital prior authorization platforms, where compliance is not a decoration added at the end. It is part of the architecture.
Labeling and claims
Labeling is where optimism often sneaks into trouble. A marketing phrase can change the intended use. A casual performance claim can require evidence. A “helps diagnose” statement may be different from a “supports review” statement. Boutiques may charge more when labeling needs heavy editing or claim control.
Quality system readiness
FDA’s premarket review is not a full quality system audit, but your submission depends on records from design controls, risk management, verification, validation, supplier files, and labeling controls. If those records are weak, the 510(k) writer becomes a document archaeologist with a headlamp.
Show me the nerdy details
A boutique may build its quote by estimating work units for each submission module: administrative forms, indications for use, 510(k) summary or statement, device description, substantial equivalence table, standards table, risk summary, software documentation, cybersecurity content, biocompatibility rationale, sterilization and shelf-life summaries, electrical safety and EMC summaries, performance testing, labeling, and final eSTAR quality control. The quote may also include meetings, document intake, issue logs, version control, project management, and one or more FDA response cycles. High-risk pricing usually appears when the boutique sees open-ended work: missing protocols, unclear claims, no predicate consensus, unresolved design changes, or test failures that may require repeat work.
Quote-Prep Checklist Before You Contact a Boutique
The faster you help a boutique understand your device, the better the quote. A vague request produces a vague fee. A clear intake package produces a sharper estimate and fewer “small clarifications” that multiply like conference room muffins.
Eligibility checklist
| Question | Why It Matters | Ready? |
|---|---|---|
| Do you know the likely product code? | Helps identify device class, guidance, and predicate patterns. | Yes / No / Unsure |
| Have you selected a predicate? | Predicate uncertainty can reshape the entire quote. | Yes / No / Need help |
| Is intended use final? | Changes in claims can require new evidence. | Yes / Draft / Marketing is still wrestling it |
| Are test reports complete? | Missing reports are major scope expanders. | Complete / In progress / Not started |
| Do you have draft labeling? | Labeling must align with indications, warnings, and evidence. | Yes / Partial / No |
Quote-prep list
- One-page device overview with intended use and target users.
- Photos, diagrams, or screenshots of the device and accessories.
- Draft instructions for use, packaging labels, and marketing claims.
- Predicate candidates and why you believe they fit.
- Test plan, completed reports, and open test questions.
- Risk management summary or hazard analysis.
- Software architecture summary, if software is involved.
- Cybersecurity summary, if connected or data-bearing.
- Biocompatibility, sterilization, shelf-life, and packaging status.
- Target submission date and commercial launch assumptions.
I have watched buyers save thousands simply by sending a clean intake folder. Not because consultants became magically generous, but because uncertainty stopped charging rent.
Mini calculator: rough consulting budget pressure
This small calculator is not a quote. It is a planning aid to help you see how complexity, missing documentation, and response support can push budget pressure upward.
510(k) Boutique Budget Pressure Calculator
Enter your inputs, then estimate pressure.
Risk Scorecard for 510(k) Projects
A 510(k) project becomes expensive when risk is discovered late. A risk scorecard gives you a practical way to talk with boutiques before the quote hardens into stone.
Visual Guide: How Scope Turns Into Price
Confirm product code, device class, and likely submission type.
Test the predicate fit and map technological differences.
List every report, rationale, and missing test needed.
Build the eSTAR package and run acceptance checks.
Budget for FDA questions, revisions, and final cleanup.
Risk scorecard
| Risk Area | Low Price Pressure | High Price Pressure |
|---|---|---|
| Predicate | Clear, recent, same intended use | Weak, old, different claims, multiple candidates |
| Testing | Reports complete and traceable | Testing not started or failures unresolved |
| Software | Simple firmware or no software | App, cloud, AI-like claims, cybersecurity exposure |
| Patient contact | Non-contact or limited contact | Long-duration, reusable, implant-adjacent, sterile pathway |
| Claims | Conservative and evidence-aligned | Marketing wants a marching band and fireworks |
Risk scoring helps your team ask the right question: “What are we paying to reduce?” A boutique that identifies the risk early may look expensive, but late risk has a habit of arriving with a larger suitcase.
Who This Is For / Not For
This guide is for people buying, budgeting, or evaluating 510(k) regulatory affairs support in the United States. That includes startup founders, product managers, quality leaders, medtech investors, operations executives, and consultants who need a plain-English pricing map.
This is for you if
- You are preparing a medical device 510(k) submission.
- You need to compare boutique proposals.
- You want to understand fixed-fee versus hourly pricing.
- You are budgeting for FDA fees, testing, and consultant work.
- You suspect your internal documentation is not as ready as the team says after coffee.
This is not for you if
- You need legal advice about FDA enforcement exposure.
- Your device likely requires PMA, De Novo, HDE, IDE, or emergency use support.
- You want a guaranteed clearance timeline.
- You expect a consultant to “just submit it” without evidence.
- You are using the 510(k) path to avoid hard testing questions.
If your product involves reimbursement, billing, provider workflow, or payer data, scope may spill beyond FDA work. Adjacent reading on US medical billing clearinghouses and pharmacy benefit managers can help commercial teams understand how regulated healthcare infrastructure creates separate cost layers after clearance.
- Know your device claims.
- Know what evidence exists.
- Know what help you are asking the boutique to provide.
Apply in 60 seconds: Write one sentence that defines exactly what your device does and for whom.
Short Story: The Founder Who Priced Only the PDF
Short Story: The Founder Who Priced Only the PDF
The founder arrived with a crisp deck, a confident launch date, and the phrase every consultant hears in haunted dreams: “We mostly just need someone to package the 510(k).” The device looked straightforward, a handheld tool with a companion app. Then the questions began. Was the app required for use? Did it store patient data? Was the reusable tip patient-contacting? Were the cleaning instructions validated? Did the predicate include the same population? Each answer opened a drawer. Inside each drawer was another drawer, because regulatory work enjoys nesting.
The first quote had seemed high. After the gap review, it looked merciful. The founder did not need a PDF packager. He needed a predicate reset, labeling cleanup, software documentation, usability planning, and test report review. The lesson was simple: do not price the submission file. Price the evidence story behind it.
That story is common. A 510(k) is not a binder. It is a claim supported by evidence. The boutique’s job is to help make that claim coherent enough for FDA review.
Common Mistakes
The most expensive 510(k) mistakes often begin as reasonable shortcuts. They feel practical in the moment. Later, they bill by the hour.
Mistake 1: Asking for a quote too early
It is fine to ask for a ballpark early. It is risky to treat that ballpark as a committed budget. If the boutique has not reviewed key documents, the estimate may be based on optimistic assumptions.
Mistake 2: Comparing only the headline fee
A $45,000 quote that includes gap assessment, eSTAR assembly, labeling review, and one FDA response cycle may be cheaper than a $30,000 quote that excludes all of them. Proposal comparison is not a beauty contest. It is a receipt inspection.
Mistake 3: Ignoring FDA acceptance checks
The FDA’s Refuse to Accept process screens 510(k)s for basic completeness before substantive review. A boutique that includes RTA-style quality control may reduce the chance of an early administrative setback. That quality control takes time, but it is better than watching your submission bounce at the front door.
Mistake 4: Letting marketing claims outrun evidence
One phrase can make the difference between a simple comparison and a complex evidence burden. “Improves diagnosis,” “automatically detects,” “clinically proven,” and “reduces complications” are not decorative frosting. They are regulatory magnets.
Mistake 5: Treating FDA response support as optional
Many teams budget through submission day and forget the possible additional information phase. That is like budgeting for a wedding and forgetting the marriage. If FDA asks questions, you need people ready to respond with discipline and speed.
Mistake 6: Choosing a boutique without device-category fit
Experience matters, but category fit matters more. A boutique excellent in orthopedic instruments may not be the best fit for SaMD. A strong diagnostics team may not be ideal for sterile surgical accessories. Ask for relevant examples, not just years in business.
- Compare inclusions and exclusions.
- Budget for FDA questions.
- Control claims before submission drafting begins.
Apply in 60 seconds: Highlight every proposal exclusion that mentions testing, labeling, software, or FDA responses.
Safety Disclaimer and When to Seek Help
This article is general educational information for US medical device teams. It is not legal advice, regulatory approval advice, clinical advice, or a substitute for qualified FDA regulatory counsel, experienced regulatory affairs professionals, quality system experts, or test labs. Medical device submissions can affect patient safety, market access, enforcement risk, investor diligence, and company survival. The stakes are not theatrical. They are real.
When to seek experienced help
Seek specialized help early if your device involves software as a medical device, clinical decision support, AI-adjacent functionality, cybersecurity, wireless connectivity, sterilization, reusable patient-contact parts, implants, diagnostics, pediatric use, home use by lay users, combination products, or significant differences from the predicate.
Also seek help if your team is debating whether a change to an existing device requires a new 510(k). FDA has guidance on when device changes may trigger a new submission, and the decision should be documented with care.
When legal counsel may be needed
Regulatory consultants and FDA attorneys often work together, but they are not the same. Consider legal counsel if there are enforcement questions, prior FDA correspondence, warning letters, import holds, competitor complaints, advertising risk, contractual representations to investors, or uncertainty about whether prior sales occurred before clearance.
FTC truth-in-advertising principles may also matter when marketing claims are involved. A medical device claim can create FDA issues, FTC issues, reimbursement issues, and customer trust issues at once. Tiny sentence, large shadow.
How to Compare Boutique Proposals
A clean proposal comparison should make scope visible. Do not ask, “Who is cheapest?” Ask, “Which proposal gives us the best risk control per dollar?” That question has a straighter spine.
Buyer checklist
| Item to Compare | Good Sign | Caution Sign |
|---|---|---|
| Scope definition | Specific modules and deliverables listed | “510(k) support” with little detail |
| Exclusions | Plain exclusions for testing, legal, clinical, translations | No exclusions, which may mean hidden assumptions |
| FDA responses | Defined support level and pricing method | Not mentioned |
| Category experience | Relevant device examples and reviewer issue awareness | Generic FDA experience only |
| Project controls | Timeline, owner map, document list, meeting rhythm | No governance plan |
Decision card: which support level fits?
Decision Card
Choose strategy-only support if you are still confirming product code, predicate, intended use, or regulatory pathway.
Choose targeted review if your internal team has drafted the submission and wants an expert RTA-style and strategy review.
Choose full-service support if your team lacks bandwidth, has complex evidence, or needs eSTAR assembly and project management.
Choose retainer support if your device company needs ongoing FDA, labeling, change-control, quality, and commercialization advice.
Questions to ask before signing
- What exact deliverables are included?
- What assumptions did you use to price this?
- What work is excluded?
- How are FDA additional information requests priced?
- Who will do the work: senior consultant, manager, writer, or subcontractor?
- How many review rounds are included?
- Do you review labeling claims for consistency with intended use?
- Do you support test protocol review, or only final report summary?
- What happens if testing fails or the predicate changes?
- Can you provide a phased option?
I once watched a buyer choose the middle-priced proposal because it had the clearest assumptions. It was not the cheapest. It was the only quote that said what would happen if the software documentation was incomplete. That sentence became the project’s seatbelt.
FAQ
How much does a 510(k) consultant cost in the US?
For narrow strategy or review work, buyers may see fees from several thousand dollars to tens of thousands. Full-service 510(k) support often runs from mid-five figures into six figures for complex devices. The FDA user fee, testing, legal review, quality system work, and lab costs are usually separate unless clearly included.
Why do 510(k) boutique quotes vary so much?
Quotes vary because boutiques make different assumptions about predicate work, evidence gaps, software documentation, labeling, testing, project management, and FDA response support. One quote may include gap analysis and one response cycle. Another may only include submission drafting from documents you provide.
Is fixed-fee 510(k) support better than hourly support?
Fixed-fee support is better when scope is clear and documents are mature. Hourly support is often better for uncertain strategy work, early gap review, or unpredictable FDA responses. Many teams do best with phased fixed fees plus hourly terms for unexpected work.
Does the FDA 510(k) fee include consultant support?
No. The FDA user fee is paid to the government for review of the submission. Consultant fees are separate professional fees paid to the regulatory affairs boutique for strategy, writing, review, project management, and response support.
What should be included in a 510(k) boutique proposal?
A useful proposal should define the submission type, deliverables, assumptions, exclusions, timeline, meeting cadence, review rounds, FDA response support, project team, client responsibilities, and change-order triggers. If the proposal is vague, ask for a clearer scope before signing.
Can a boutique guarantee FDA clearance?
No reputable boutique should guarantee FDA clearance. A strong consultant can improve the quality, completeness, and strategy of the submission, but FDA makes the clearance decision based on the evidence and substantial equivalence review.
Should a startup hire a boutique before testing is complete?
Often, yes. Early regulatory input can help shape the test plan, predicate comparison, labeling claims, and submission strategy. Waiting until all testing is done can be costly if the tests do not match FDA expectations or the intended use changed along the way.
What is the biggest hidden cost in 510(k) support?
The biggest hidden cost is usually remediation. This includes rewriting labeling, fixing weak test reports, changing predicate strategy, creating missing software documentation, repeating tests, or responding to FDA questions that could have been anticipated earlier.
Do small businesses pay less for FDA 510(k) fees?
Qualified small businesses may receive a reduced FDA user fee through the Small Business Determination program. That reduction applies to FDA’s fee, not automatically to consultant fees. Some boutiques may offer startup-friendly phasing, but that is a business decision, not an FDA program.
How early should I request boutique quotes?
Request early ballparks when you are planning the budget, but request formal proposals after you can share a device overview, intended use, predicate candidates, draft labeling, testing status, and known gaps. Better inputs create better quotes.
Conclusion
The quiet trick in 510(k) pricing is that you are not buying a document. You are buying help turning device evidence into a credible FDA submission story. That is why two US FDA regulatory affairs boutiques can quote different numbers and both may be responding to different levels of risk.
The curiosity loop from the beginning closes here: the fog clears when scope becomes visible. In the next 15 minutes, gather your device overview, intended use, predicate candidates, testing status, labeling draft, and open gaps into one folder. Then ask each boutique to price the same scope, list exclusions, and explain how FDA response support works.
Calm buying beats frantic buying. A good quote should feel less like a magic number and more like a map: where you are, what is missing, who owns each step, and what happens if the path bends.
Last reviewed: 2026-05
